Clinical Management Recommendations

Meeting the Challenges of the Dermatomyositis Workup: A Management Paradigm Amena Alkeswani, Lauren V Graham

Full Article PDF 53-58

In-Depth Reviews

Caffeine in the Treatment of Atopic Dermatitis and Psoriasis: A Review Mais Bassam Alashqar

Full Article PDF 59-71

Review of suicide and depression in psoriasis and management of suicide warnings in patients treated with psoriasis drugs Emily Lebowitz, Mark Lebwohl

Full Article PDF 72-81

Research Letters

Survey of Sun Protection Policies in Juvenile Detention Centers in Pennsylvania: Are we also Protecting Vulnerable Communities? Christen Botros Samaan

Full Article PDF 82-84

Brief Articles

Histopathologic discordance in melanoma can have substantial impacts on patient care Alex Glazer, Clay Cockerell

Full Article PDF 85-89

Subcutaneous panniculitis-like T-Cell lymphoma: A mixed diagnostic approach to diagnosing a vague clinical picture Callie Roberts Hill, Apphia Wang, Boni E. Elewski, Peter G Pavlidakey

Full Article PDF 90-97

Geometric Facial Erosions on a Newborn Matthew LaCour

Full Article PDF 98-101

Lues maligna in an immunocompetent male Carly Dunn, Danielle S. Applebaum

Full Article PDF 102-104

Frequently debrided and misdiagnosed: Post-surgical pyoderma gangrenosum Lindsey Wold Fraser, Stephanie A Castillo, Shabnam Momtahen, Michael Shane Chapman

Full Article PDF 105-108

Short Communications

A female with thick intertriginous vegetative plaques Brandon T Beal, Hannah L Cundall, Anthony P Fernandez

Full Article PDF 109-110

Successful Treatment of Vitiligo with Crisaborole 2% Ointment William Tausend, Paige Hoyer, Morgan Arnold, Keith Wagner, Lindy Ross, Brandon P Goodwin, Janice M Wilson

Full Article PDF 111-113

Compelling Comments

Adrenal Insufficiency and its Presidential Touch Christopher Dallo, Benjamin Falck

Full Article PDF 114-115

Nobel Niels Jacob E Benavidez

Full Article PDF 116-117

Rising Derm Stars® Abstracts

SkinSpecs: A solution that addresses an unmet need for tracking chronic skin diseases in the office and at home Olga Afanasiev

Full Article PDF 118-119

Pilot study of use of neural network for quantitative before-and-after analysis of dermatologic cosmetic procedures Adam Aronson

Full Article PDF 120-121

Access to Injectable Biologic Medications by Medicare Beneficiaries: Geographic Distribution of U.S. Dermatologist Prescribers Jeffrey Cohen

Full Article PDF 122-125

De novo versus nevus-associated melanomas: differences in associations with prognostic indicators and survival Rachel Cymerman

Full Article PDF 126

Photodynamic therapy with δ-aminolevulinic acid and blue light for the treatment of actinic cheilitis Alicia Dagrosa

Full Article PDF 127-128

Post-operative pain after Mohs micrographic surgery: analyzing physician perceptions of postoperative pain and how those perceptions affect opioid prescribing practices Joshua Eikenberg

Full Article PDF 129-130

Effect of Suture Spacing on Wound Cosmesis Karin Eshagh

Full Article PDF 131

In-Vitro Evaluation of Pre-Injection Aspiration as Safety Checkpoint for Hyaluronic Fillers. Aaron Farberg

Full Article PDF 132-133

Development and validation of the tape-to-trace method: An objective outcome measure for linear postoperative scars Stephanie Feldstein

Full Article PDF 134-136

Hairy Legs Revisited: Peroneal Alopecia Katherine Glaser

Full Article PDF 137-138

The Ram Relaxation Technique: A Painless Biopsy Method. A Needle-free, Anesthesia-free Shave Biopsy Approach Jacquiline Habashy

Full Article PDF 139-140

Characterizing The Alopecia Areata Microbiome Margit Juhasz

Full Article PDF 141-143

Cell Cycle Activators and Tumor Suppressors that Correlate with Melanoma Progression Michelle Min

Full Article PDF 144-145

Tackling lower extremity surgical site infection in dermatologic surgery Neera Nathan

Full Article PDF 146-147

Impact of Consumer Preferences, Product Characteristics, and Unregulated Marketing Claims on Online Sunscreen Purchases Giselle Prado

Full Article PDF 148

Understanding of abbreviations in dermatology: A survey of primary care providers.Understanding of abbreviations in dermatology: A survey of primary care providers Bethany Rohr

Full Article PDF 149

Long Term Outcomes for Basal Cell Carcinoma Treated with Vismodegib Extended Alternate Day Dosing Ethan Routt

Full Article PDF 150-151

The use of doxycycline in lichen planopilaris and frontal fibrosing alopecia: a retrospective study of 138 patients at a tertiary referral clinic Janice Tiao

Full Article PDF 155-156

Atypical Intraepidermal Melanocytic Proliferation – But now what? Shira Wieder

Full Article PDF 157-158

Wedding Dermatology: a proposed timeline to optimize skin clearance and the avoidance of a true dermatologic emergency Richard Winkelmann

Full Article PDF 159-160

Acne & Rosacea

Efficacy and Safety of FMX103 (1.5% Minocycline Foam) in the Treatment of Moderate to Severe Papulopustular Rosacea: Results from two Phase 3 Randomized, Multicenter, Double Blind, Vehicle Controlled Studies Linda Stein Gold, James Q Del Rosso, Neal D Bhatia, et al.

Poster PDF 161

Pharmacokinetics of Minocycline Foam FMX103 in Subjects With Moderate-to-Severe Facial Papulopustular Rosacea Under Maximum-Use Conditions: Results of a Phase 1 Study Terry Jones, Iain Stuart

Poster PDF 162

The Effect of an Anti-Inflammatory Botanical Cleanser/Night Mask Combination on Facial Redness Reduction Zoe D Draelos

Poster PDF 163

Atopic Dermatitis

Variables Affecting Delivery of Glycopyrronium Tosylate Through Human Skin In Vitro Franceso Caserta, Jon Lenn, Hans Hofland

Poster PDF 164

Melanoma

Genes and biological functions governing intrinsic tumor biology utilized in cutaneous melanoma risk assessment through a clinically available 31-gene expression profile test Sarah J Kurley, Kyle R Covington, Kristen M Plasseraud, et al.

Poster PDF 165

Non-Melanoma Skin Cancers and Benign Cutaneous Tumors

Safety of Hydrogen Peroxide Topical Solution, 40% (w/w) in Patients With Skin of Color and Seborrheic Keratoses: Pooled Analysis of Two Phase 3, Randomized, Double- Blind, Vehicle-Controlled, Parallel-Group Studies Catherine Hren, Eduardo Tschen, Terry Jones, et al.

Poster PDF 166

Assessing Patient Satisfaction With Hydrogen Peroxide Topical Solution, 40% (w/w) Treatment of Seborrheic Keratoses on the Face, Neck, and Décolletage: Objectives and Design of the Phase 4, Open-Label SK-FAN Study Janet Dubois, Kimberly Grande, Judith Schnyder, et al.

Poster PDF 167

Efficacy and Safety of Ingenol Mebutate in Patients With Actinic Keratosis on Face and Scalp: Subgroup Analysis of Two Vehicle-Controlled Trials According to Age (<65 and ≥65 Years) Hee Kim, Jes Hansen, Mads Faurby, et al.

Poster PDF 168

Phase 1 Study of Cemiplimab, a Human Monoclonal Anti-PD-1 Antibody, in Patients with Unresectable Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC): Longer Follow-up Efficacy and Safety Data Taofeek Owonikoko, Kyriakos Papadopoulos, Melissa Johnson, et al.

Poster PDF 169

Psoriasis

Efficacy and Safety of Apremilast in Patients With Moderate to Severe Plaque Psoriasis of the Scalp: Results of a Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study Abby Van Voorhees, Linda Stein Gold, Mark Lebwohl, et al.

Poster PDF 170

A Phase 1 Open -Label Multicenter Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Calcipotriene Foam, 0.005% Applied Under Maximal Use Conditions in Adolescent Subjects with Plaque Psoriasis Adelaide Hebert, Debbie Glaab, Rhonda Schreiber

Poster PDF 171

Demographic and Clinical Characteristics of Patients With Plaque Psoriasis Initiating Secukinumab in Clinical Practice: Data From US Dermatology Electronic Medical Records Paul Yamauchi, Chi-Chang Chen, Yao Ding, et al.

Poster PDF 172

Secukinumab Is Associated With Improvements in Real-World Effectiveness Outcomes Through 12 Months of Follow-Up in Patients With Plaque Psoriasis: Analysis of US Dermatology Electronic Medical Records Paul Yamauchi, Chi-Chang Chen, Yao Ding, et al.

Poster PDF 173

The Efficacy of Certolizumab Pegol Re-Treatment on Plaque Psoriasis Following a Blinded Treatment Break: Results from the CIMPACT Trial M Lebwohl, V Piguet, H Sofen, et al.

Poster PDF 174

Durable Improvement in Patient Reported Outcomes across DLQI Subdomains Over 48 Weeks in Chronic Plaque Psoriasis Patients Treated with Certolizumab Pegol in Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2) A Blauvelt, RB Warren, K Reich, et al.

Poster PDF 175